Table 3.
Differences in transcript levels in colorectal mucosa between poor and good responders to 5-FU-based chemotherapy. Transcript levels of 5-FU pathway genes were compared in mucosas of patients in the testing set divided into groups of poor responders (n = 13) and good responders (n = 13) to the first line chemotherapy regimens based on 5-FU
| Gene | Expression level in poor responders vs. good responders | ||
|---|---|---|---|
| Fold differenceb | Standard errorb | P-valuea | |
| DPYD | 0.76 | 0.31–1.69 | 0.259 |
| DPYS | 0.91 | 0.10–6.89 | 0.434 |
| PPAT | 0.88 | 0.20–3.63 | 0.086 |
| RRM2 | 0.31 | 0.11–1.46 | 0.038 |
| RRM1 | 0.59 | 0.22–1.18 | 0.014 |
| SLC29A1 | 0.76 | 0.17–2.73 | 0.369 |
| TK1 | 0.87 | 0.18–3.66 | 0.157 |
| TYMP | 0.56 | 0.12–2.46 | 0.130 |
| TYMS | 0.82 | 0.15–3.77 | 0.121 |
| UCK1 | 0.85 | 0.23–1.96 | 0.369 |
| UCK2 | 0.74 | 0.17–2.42 | 0.681 |
| UMPS | 0.68 | 0.23–1.21 | 0.024 |
| UPB1 | 0.91 | 0.26–2.85 | 0.479 |
| UPP1 | 0.61 | 0.16–2.10 | 0.106 |
Footnotes:
aAnalyzed by the Mann-Whitney test
bFold changes and standard error calculated by the REST2009 program
Significant results in bold